References

Export 189 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is F  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
I. Füsgen, [Rehabilitation of the aged]., Versicherungsmedizin, vol. 44, no. 3, pp. 94-7, 1992.
I. Füsgen, [The geriatric day care clinic--a model also for the management of demented patients?]., Versicherungsmedizin, vol. 44, no. 4, pp. 137-9, 1992.
M. Fulks, Stout, R. L., and Dolan, V. F., Mortality associated with bilirubin levels in insurance applicants., J Insur Med, vol. 41, no. 1, pp. 49-53, 2009.
M. Fulks, Stout, R. L., and Dolan, V. F., Albumin and all-cause mortality risk in insurance applicants., Journal of insurance medicine (New York, N.Y.), vol. 42, pp. 11–17, 2010.
M. Fulks, Kaufman, V., Clark, M., and Stout, R. L., NT-proBNP Predicts All-Cause Mortality in a Population of Insurance Applicants, Follow-up Analysis and Further Observations., J Insur Med, vol. 47, no. 2, pp. 107-113, 2017.
M. Fulks, Stout, R. L., and Dolan, V. F., Using liver enzymes as screening tests to predict mortality risk., J Insur Med, vol. 40, no. 3-4, pp. 191-203, 2008.
M. Fulks, Stout, R. L., and Dolan, V. F., Serum globulin predicts all-cause mortality for life insurance applicants., Journal of insurance medicine (New York, N.Y.), vol. 44, pp. 93–98, 2014.
M. Fulks, Stout, R. L., and Dolan, V. F., Changing the "Normal Range" for Blood Pressure from 140/90 to 130/Any Improves Risk Assessment., J Insur Med, vol. 45, no. 1, pp. 28-33, 2015.
M. Fulks, Dolan, V. F., and Stout, R. L., 2014 CRL Build Study of Life Insurance Applicants., Journal of insurance medicine (New York, N.Y.), vol. 46, pp. 13–19, 2016.
M. Fulks, Stout, R. L., and Dolan, V. F., Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk., Journal of insurance medicine (New York, N.Y.), vol. 43, pp. 169–177, 2012.
M. Fulks, Stout, R. L., and Dolan, V. F., The use of modeling for associating test values and mortality risk., J Insur Med, vol. 43, no. 1, p. 50, 2012.
M. Fulks, Dolan, V. F., and Stout, R. L., 2014 CRL Blood Pressure Study of Life Insurance Applicants., Journal of insurance medicine (New York, N.Y.), vol. 45, pp. 17–27, 2015.
M. Fulks, Stout, R. L., and Dolan, V. F., Mortality associated with bilirubin levels in insurance applicants., Journal of insurance medicine (New York, N.Y.), vol. 41, pp. 49–53, 2009.
M. Fulks, Dolan, V. F., and Stout, R. L., Hemoglobin Screening Independently Predicts All-Cause Mortality., J Insur Med, vol. 45, no. 2, pp. 75-80, 2015.
M. Fulks, Kaufman, V., Clark, M., and Stout, R. L., NT-proBNP Predicts All-Cause Mortality in a Population of Insurance Applicants, Follow-up Analysis and Further Observations., J Insur Med, vol. 47, no. 2, pp. 107-113, 2017.
M. Fulks, Stout, R. L., and Dolan, V. F., Urine protein/creatinine ratio as a mortality risk predictor in non-diabetics with normal renal function., J Insur Med, vol. 43, no. 2, pp. 76-83, 2012.
M. Fulks, Stout, R. L., and Dolan, V. F., Association of cholesterol, LDL, HDL, cholesterol/ HDL and triglyceride with all-cause mortality in life insurance applicants., J Insur Med, vol. 41, no. 4, pp. 244-53, 2009.
M. Fulks, Stout, R. L., and Dolan, V. F., Changing the "Normal Range" for Blood Pressure from 140/90 to 130/Any Improves Risk Assessment., Journal of insurance medicine (New York, N.Y.), vol. 45, pp. 28–33, 2015.
M. Fulks, Stout, R. L., and Dolan, V. F., Albumin and all-cause mortality risk in insurance applicants., J Insur Med, vol. 42, no. 1, pp. 11-7, 2010.
M. Fulks, Stout, R. L., and Dolan, V. F., The use of modeling for associating test values and mortality risk., Journal of insurance medicine (New York, N.Y.), vol. 43, p. 50, 2012.
M. Fulks, Stout, R. L., and Dolan, V. F., Serum globulin predicts all-cause mortality for life insurance applicants., J Insur Med, vol. 44, no. 2, pp. 93-8, 2014.
M. Fulks, Dolan, V. F., and Stout, R. L., Hemoglobin Screening Independently Predicts All-Cause Mortality., Journal of insurance medicine (New York, N.Y.), vol. 45, pp. 75–80, 2015.
M. Fulks, Dolan, V. F., and Stout, R. L., 2014 CRL Build Study of Life Insurance Applicants., J Insur Med, vol. 46, no. 1, pp. 13-9, 2016.
M. Fulks, Stout, R. L., and Dolan, V. F., Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk., J Insur Med, vol. 43, no. 3, pp. 169-77, 2012.
M. Fulks, Stout, R. L., and Dolan, V. F., Urine protein/creatinine ratio as a mortality risk predictor in non-diabetics with normal renal function., Journal of insurance medicine (New York, N.Y.), vol. 43, pp. 76–83, 2012.

Pages

Subscribe to Syndicate